MassBio panel tackles why rare disease treatments cost so much

Home › MassBio panel tackles why rare disease treatments cost so much

David Meeker, right, CEO of Genzyme Corp., speaks at a panel on pricing of rare disease therapies at the MassBio annual meeting.

20.05	Eastern North Pacific Tropical Weather Outlook
20.05	Atlantic Tropical Weather Outlook
20.05	China hits back at US and EU as trade rows deepen
20.05	How should countries deal with falling birth rates?
20.05	Eastern North Pacific Tropical Weather Outlook
20.05	Atlantic Tropical Weather Outlook
20.05	Water investors have withdrawn billions, says research
19.05	Atlantic Tropical Weather Outlook
More »

je.st